65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer

Overview of attention for article published in Lung Cancer: Targets and Therapy, November 2017

Altmetric Badge

Mentioned by

reddit: 1 Redditor

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Reddit Dimensions citations

So far, Altmetric has seen 1 Reddit thread.

65Plus: open-label study of bevacizumab in combination with pemetrexed

User montaukwhaler, in the non small cell lung cancer subreddit, 07 Nov 2017